Literature DB >> 29046964

Differences in maxillomandibular morphology among patients with mucopolysaccharidoses I, II, III, IV and VI: a retrospective MRI study.

Till Koehne1, Anja Köhn2, Reinhard E Friedrich3, Uwe Kordes4, Thorsten Schinke5, Nicole Muschol2, Bärbel Kahl-Nieke6.   

Abstract

OBJECTIVE: The aims of this study were to analyze the maxillomandibular morphology of patients with mucopolysaccharidosis (MPS) type I, II, III, IVa and VI and to evaluate the craniofacial effect of hematopoietic stem cell transplantation (HCST) in MPS I.
MATERIALS AND METHODS: One hundred head magnetic resonance images were retrospectively analyzed from 41 MPS and 27 control individuals. The width, height and length of the maxilla and mandible were plotted against age and the means of controls, MPS I, MPS II and MPS III were statistically compared. To determine the effect of HSCT in MPS I, jaw morphology was compared between MPS I patients with full donor chimerism versus patients with mixed/no donor chimerism.
RESULTS: Maxillary dimensions were not statistically different between the MPS types. The height and length of the mandible were clearly smaller in MPS I as compared to those in controls, MPS II and MPS III. This was associated with progressive resorption of the mandibular condyles in MPS I, which was also observed in MPS II and VI, but not in MPS III or IVa. Whereas the success of HCST did not affect these changes, mandibular width was significantly smaller in MPS I individuals with full donor chimerism.
CONCLUSION: MPS I individuals have a smaller mandible as compared to control, MPS II and MPS III individuals due to progressive condylar degeneration. These abnormalities are also evident following successful HSCT. CLINICAL RELEVANCE: Clinicians should be aware of specific differences in mandibular morphology and condylar involvement among the MPS subtypes.

Entities:  

Keywords:  Cephalometry; Craniofacial; Hematopoetic stem cell transplantation; MRI; Mucopolysaccharidosis; OSAS

Mesh:

Year:  2017        PMID: 29046964     DOI: 10.1007/s00784-017-2240-x

Source DB:  PubMed          Journal:  Clin Oral Investig        ISSN: 1432-6981            Impact factor:   3.573


  42 in total

1.  Dentoskeletal morphology in children with juvenile idiopathic arthritis compared with healthy children.

Authors:  S Sidiropoulou-Chatzigianni; M A Papadopoulos; G Kolokithas
Journal:  J Orthod       Date:  2001-03

2.  Evaluation of micrognathia with emphasis on late development of the mandible.

Authors:  B E BROMBERG; R PASTERNAK; R H WALDEN; L R RUBIN
Journal:  Plast Reconstr Surg Transplant Bull       Date:  1961-11

3.  Angiotensin receptor blockade mediated amelioration of mucopolysaccharidosis type I cardiac and craniofacial pathology.

Authors:  Mark J Osborn; Beau R Webber; Ronald T McElmurry; Kyle D Rudser; Anthony P DeFeo; Michael Muradian; Anna Petryk; Benedikt Hallgrimsson; Bruce R Blazar; Jakub Tolar; Elizabeth A Braunlin
Journal:  J Inherit Metab Dis       Date:  2016-10-14       Impact factor: 4.982

4.  Orofacial features of Scheie (Hurler-Scheie) syndrome (alpha-L-iduronidase deficiency).

Authors:  O Keith; C Scully; G M Weidmann
Journal:  Oral Surg Oral Med Oral Pathol       Date:  1990-07

Review 5.  Dental findings in three siblings with Morquio's syndrome.

Authors:  I Rølling; N Clausen; B Nyvad; S Sindet-Pedersen
Journal:  Int J Paediatr Dent       Date:  1999-09       Impact factor: 3.455

6.  Oral manifestations of Morquio's syndrome.

Authors:  M Sela; E Eidelman; S Yatziv
Journal:  Oral Surg Oral Med Oral Pathol       Date:  1975-04

7.  A clinical multicenter study of orofacial features in 26 brazilian patients with different types of mucopolysaccharidosis.

Authors:  Erlane Marques Ribeiro; Cristiane S R Fonteles; Adriana Bezerra Freitas; Karla Shangela da Silva Alves; André Jalles Monteiro; Carlos Antônio Bruno da Silva
Journal:  Cleft Palate Craniofac J       Date:  2014-06-11

8.  Mucopolysaccharidosis: radiographic findings in a series of 16 cases.

Authors:  Dmitry José de Santana Sarmento; Sérgio Henrique Gonçalves de Carvalho; Saulo Leonardo Sousa Melo; Fátima Roneiva Alves Fonseca; Denise Nóbrega Diniz; Patrícia Meira Bento; Germana de Queiroz Tavares Borges Mesquita; Daniela Pita de Melo
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol       Date:  2015-08-22

9.  The prevalence of and survival in Mucopolysaccharidosis I: Hurler, Hurler-Scheie and Scheie syndromes in the UK.

Authors:  David Moore; Martin J Connock; Ed Wraith; Christine Lavery
Journal:  Orphanet J Rare Dis       Date:  2008-09-16       Impact factor: 4.123

10.  Musculoskeletal manifestations in mucopolysaccharidosis type I (Hurler syndrome) following hematopoietic stem cell transplantation.

Authors:  Mona Schmidt; Sandra Breyer; Ulrike Löbel; Sinef Yarar; Ralf Stücker; Kurt Ullrich; Ingo Müller; Nicole Muschol
Journal:  Orphanet J Rare Dis       Date:  2016-07-08       Impact factor: 4.123

View more
  1 in total

1.  Early enzyme replacement therapy prevents dental and craniofacial abnormalities in a mouse model of mucopolysaccharidosis type VI.

Authors:  Rohit Nagpal; Gina Georgi; Sarah Knauth; Carmen Schmid-Herrmann; Nicole Muschol; Thomas Braulke; Bärbel Kahl-Nieke; Michael Amling; Thorsten Schinke; Till Koehne; Julian Petersen
Journal:  Front Physiol       Date:  2022-09-21       Impact factor: 4.755

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.